Managing symptoms and side effects during brain tumor illness

Expert Review of Neurotherapeutics

Volumn 5, Issue 6 SUPPL., 2005, Pages

  Stewart Amidei, Christina ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cognitive behavioral effects; End of life issues; Headache; Malignant brain tumor; Medical complications; Seizure

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; ALENDRONIC ACID; ANTIMIGRAINE AGENT; BUTALBITAL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; CARBAMAZEPINE; CLONAZEPAM; CYCLOOXYGENASE 2; DEXAMETHASONE; DIPHENHYDRAMINE; ETIRACETAM; FELBAMATE; GABAPENTIN; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; LAMOTRIGINE; NARCOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; STEROID; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

ABDOMINAL PAIN; APLASTIC ANEMIA; ASTHENIA; ATAXIA; BEHAVIOR DISORDER; BLEEDING; BRAIN EDEMA; BRAIN TUMOR; CATARACT; CLINICAL FEATURE; COGNITIVE DEFECT; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DEPRESSION; DIABETES MELLITUS; DIPLOPIA; DIZZINESS; ELECTROLYTE DISTURBANCE; EPILEPSY; EUPHORIA; FATIGUE; FEMUR HEAD NECROSIS; FRACTURE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEADACHE; HEARTBURN; HUMAN; HYPERGLYCEMIA; INFECTION; INSOMNIA; JOINT NECROSIS; LEG CRAMP; LIVER TOXICITY; MEDICAL DECISION MAKING; MEMORY DISORDER; MOOD DISORDER; MUSCLE WEAKNESS; MYOPATHY; NAUSEA; NYSTAGMUS; OSTEOPOROSIS; PEPTIC ULCER; PERSONALITY DISORDER; PNEUMONIA; POTASSIUM DEPLETION; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SEIZURE; SIDE EFFECT; SODIUM RETENTION; SOMNOLENCE; STEVENS JOHNSON SYNDROME; TERMINAL CARE; TREMOR; URINARY TRACT INFECTION; VISUAL IMPAIRMENT; VOMITING; WATER RETENTION;

ANTICONVULSANTS; BRAIN NEOPLASMS; COGNITION DISORDERS; DEXAMETHASONE; EXPERT TESTIMONY; HEADACHE; HUMANS; SEIZURES;

EID: 27944432904     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.5.5.71     Document Type: Review

References (23)

1. Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 2004-2005. CBTRUS, Chicago, IL, USA (2004).
2. Pfund Z, Szapary L, Jaszberenyi O, Nagy F, Czopf J. Headache in intracranial tumors. Cephalgia 19(9), 787-790 (1999).
3. Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J. Nurs. Schol. 36(3), 197-206 (2004).
4. Marks DR, Rapoport AM. Practical evaluation and diagnosis of headache. Sem. Neurol. 17(4), 307-312 (1997).
5. Wick W, Kuker W. Brain edema in neurooncology: radiological assessment and management. Onkologie 27(3), 261-266 (2004).
6. th edition). Medical Economics Company, Montvale, NJ, USA (2004).
7. Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 52(3), 617-622 (1999).
8. Gilbert M, Armstrong T. Management of seizures in the adult patient with cancer. Cancer Practice 3(3), 143-149 (1995).
9. Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. American Academy of Neurology MN, USA (2000).
10. Sawaya RE, Ligon BL. Thromboembolic complications associated with brain tumors. J. Neuro-oncol. 22(2), 173-181 (1994).
11. Norris LK, Grossman SA. Treatment of thromboembolic complications in patients with brain tumors. J. Neuro-oncol. 22(2) 127-137 (1994).
12. Wen PY, Marks PW. Medical management of patients with brain tumors. Curr. Opin. Oncol. 14(3), 299-307 (2002).
13. Rabbitt J, Page MS. Selected complications in neuro-oncology patients. Sem. Oncol. Nurs. 14(1), 53-60 (1998).
14. Gadisseux P, Ward JD, Young HF, Becker DP. Nutrition and the neurosurgical patient. J. Neurosurg. 60(2), 219-232 (1984).
15. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J. Neuro-oncol. 57(1), 41-49 (2002).
16. Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiforme. Oncol. Nurs. For. 26(5), 921-925 (1999).
17. Hahn CA, Dunn RH, Logue PE et al. Prospective study of neuropsychological testing and quality-of-life assessment of adults with primary malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 55(4), 992-999 (2003).
18. Taphoorn MJ. Neurocognitive sequelae in the treatment of low-grade gliomas. Sem. Oncol. 30(6 Suppl. 19), 45-48 (2003).
19. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psycho-Oncol. 6(3), 169-177 (1997).
20. Kirshblum S, O'Dell MW, Ho C, Barr K. Rehabilitation of persons with central nervous system tumors. Cancer 92(4 Suppl.), 1029-1038 (2001).
21. Huang ME, Wartella JE, Kreutzer JS. Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch. Phys. Med. Rehabil. 82(11), 1540-1546 (2001).
22. Newton HB, Malkin, MG. Ethical issues in neuro-oncology. Sem. Neurol. 17(3), 219-226 (1997).
23. Voltz R, Borasio GD. Palliative therapy in the terminal stage of neurological disease. J. Neurol. 244(Suppl. 4), S2-10 (1997).